Please note that all agenda timings are Eastern Time

8:00 am

Registration & Networking Coffee

8:50 am Chairman’s Opening Remarks

Biomarker Targeting Through Multimodal Imaging Applications

9:00 am Building on the Key Relationship: Setting the Goals Between Industry & Academic Imaging

9:20 am Development of Molecularly Targeted Imaging Agents to Advance Cancer Stratification & Treatment

9:40 am Why Imaging Biomarkers Fail?

  • John Waterton Professor - Translational Imaging, University of Manchester

10:10 am Pitfalls and Promises in the Development of Imaging Biomarkers for Drug Development in Oncology

10:30 am Interactive Panel Discussion – Developing an Imaging Biomarker Strategy

11:00 am

Virtual Speed Networking & Refreshments

Preclinical Technical Advances Across Imaging Modalities

11:30 am Assessing the Effects of VEGF Blockade in Preclinical Tumor Models Using Non-Invasive Imaging Modalities

11:50 am Chemical Tools for Dynamic & Multicolor Optical Imaging In Vivo

12:10 pm Bridging the Preclinical-Clinical Gap

  • Vaishali Shinde Associate Director - Clinical Biomarker Innovation & Development, Quantitative Translational Sciences, Takeda

12:30 pm Interactive Panel Discussion

1:00 pm

Networking & Lunch Break

Advancing Imaging Strategy to Create Robust Translational Outcomes

2:00 pm Multimodal Applications to Understand the Tumor Microenvironment

  • Mark Pagel Professor, Department of Cancer Systems Imaging Department of Cancer Systems Imaging, Division of Diagnostic Imaging, MD Anderson Cancer Center

2:20 pm Multimodal Imaging for Improved Drug Efficacy Understanding

  • David Leung Medical Director, Oncology Imaging, Bristol-Myers Squibb

2:40 pm An AI-Powered Digital Pathology Toolbox to Advance Oncology Biomarker Development

3:00 pm Panel Discussion – The Future of Digital Pathology: Challenging Traditional Standard of Care Guidelines with AI Data

  • Cleopatra Kozlowski Senior Scientist, Genentech
  • David Leung Medical Director, Oncology Imaging, Bristol-Myers Squibb
  • Mark Pagel Professor, Department of Cancer Systems Imaging Department of Cancer Systems Imaging, Division of Diagnostic Imaging, MD Anderson Cancer Center

3:30 pm

Networking Afternoon Break

Exploring Novel Modalities across Preclinical & Clinical Stages

4:00 pm Evaluating Drug Response From Data Analysis to Advance Candidate Development

  • Mohan Singh Investigator: Imaging Mass Cytometry, GlaxoSmithKline

4:20 pm Multimodal Imaging for Translating Stem Cell-Based Therapy into the Clinic

  • Khalid Shah Vice Chair of Research, Brigham and Women's Hospital Director, Center for Stem Cell Therapeutics and Imaging, Brigham & Women's Hospital

4:40 pm Imaging the Tumor Environment

5:00 pm Roundtable Discussions

Synopsis

Roundtable A: Cost Effectiveness of Utilizing Targeted Imaging to Improve Clinical Trial Outcomes
Roundtable B: Discussing Image Quality vs Quantity – Challenges of Monitoring Tumors in Real Time
Roundtable C: Incorporating the Value of Imaging Agents into PI/II Clinical Trial Design

5:45 pm Chairman’s Closing Remarks & Virtual Happy Hour